Hay existencias
GLOW Blend: Una formulación de investigación consolidada de BPC 157 (10 mg), TB 500 (10 mg) y GHK-Cu (50 mg).
$285.00
Hay existencias
GLOW Blend es una formulación de investigación multipéptido que combina tres péptidos bien caracterizados
BPC 157
TB 500 Timosina Beta 4
y el complejo de cobre tripéptido GHK Cu
Se suministra como una mezcla de grado de investigación para su uso en modelos de laboratorio que investigan la reparación tisular, la angiogénesis, la regulación de la matriz extracelular y la señalización relacionada con la inflamación.
BPC 157
Un pentadecapeptido sintético derivado originalmente de un fragmento de proteína gástrica.
En sistemas preclínicos, se ha utilizado para estudiar la angiogénesis, la migración de fibroblastos y la reparación epitelial, con trabajos centrados en vías que incluyen el receptor 2 de VEGF, componentes de adhesión focal como FAK y paxilina, y la señalización relacionada con el óxido nítrico en modelos de lesión tisular.
TB 500 Timosina Beta 4
Un péptido de cuarenta y tres aminoácidos que se une a la actina, secuestra la actina G y modula la dinámica citoesquelética.
Es ampliamente utilizado en la investigación sobre migración celular, angiogénesis a través de mecanismos asociados a VEGF, movilización de células progenitoras y reparación de miocardio, dermis y tejido conectivo en modelos animales.
GHK Cu
Un complejo de cobre tripéptido compuesto por glicil histidil lisina unida a Cu dos más.
Se emplea en estudios de reparación de heridas, síntesis de colágeno y otras proteínas de la matriz, biología del folículo piloso y respuestas antioxidantes y antiinflamatorias, incluyendo trabajos sobre la señalización de TGF beta y la regulación de la metaloproteinasa de matriz. Al combinar estos tres agentes, GLOW Blend permite a los investigadores exponer tejidos o sistemas celulares a señales concurrentes que actúan sobre el crecimiento vascular, la remodelación citoesquelética, la síntesis de la matriz y el tono inflamatorio. Este diseño apoya la investigación de cómo vías superpuestas pero distintas interactúan para dar forma a las trayectorias de curación y la calidad del tejido en experimentos controlados.
Uso previsto
GLOW Blend está destinado exclusivamente a experimentos in vitro, preparaciones ex vivo y otras aplicaciones de investigación de laboratorio controladas, incluidos estudios en animales realizados bajo la supervisión adecuada.
modelos multifactoriales de heridas e incisiones, paradigmas de reparación dérmica y del tejido conectivo, estudios de angiogénesis y calidad microvascular, investigaciones de remodelación de la matriz y arquitectura de cicatrices.
No está destinado para uso humano ni veterinario.
No está destinado para el diagnóstico, tratamiento, cura, prevención o mitigación de ninguna enfermedad, problema cosmético o afección médica.
No es un medicamento, alimento, complemento alimenticio, cosmético ni dispositivo médico.
Formulación de tres péptidos que combina BPC 157, TB 500 Timosina Beta 4 y GHK Cu en un solo vial.
Diseñado para la investigación sobre angiogénesis concurrente, migración celular, producción de matriz extracelular y modulación de la inflamación.
Adecuado para modelos que evalúan respuestas tisulares musculoesqueléticas, dermatológicas y postquirúrgicas bajo un estímulo de múltiples vías.
Fabricado bajo condiciones controladas con confirmación analítica de la identidad de los componentes y la composición de la mezcla.
GLOW Blend combines three peptides that each have established roles in tissue healing and inflammation control. BPC 157 TB 500 Thymosin Beta 4 and GHK Cu are individually used in preclinical models to study vascular growth matrix remodeling cell migration and immune modulation. The research on GLOW Blend focuses on how these three pathways interact when present simultaneously in the same tissue environment. The central question is whether coordinated activation of multiple repair mechanisms produces greater efficacy or durability of healing compared with single peptide exposures.
TB 500 and BPC 157 are both employed independently in studies of new blood vessel formation. TB 500 works through upregulation of vascular endothelial growth factor and support of endothelial cell migration while BPC 157 influences VEGF receptor 2 signaling and nitric oxide pathways that regulate vasodilation and capillary extension.
GHK Cu contributes to this axis by enhancing endothelial cell proliferation and supporting pericyte recruitment and vessel maturation. In GLOW Blend models investigators can observe how simultaneous activation of these distinct vascular mechanisms influences capillary density distribution perfusion kinetics and long term vessel stability.
Typical endpoints include tube formation assays in vitro capillary counts in wound sections blood flow measurements and pericyte coverage assessment. The convergence of VEGF signaling FAK paxillin pathways and nitric oxide tone creates a more complete pro angiogenic environment than any single peptide alone can provide.
TB 500 is foundational to cell migration research because it regulates actin polymerization and cytoskeletal organisation which are essential for cells to move and reshape.
BPC 157 promotes fibroblast migration through FAK and paxillin phosphorylation and influences how cells engage with and remodel extracellular matrix.
GHK Cu stimulates fibroblast function directly and modulates gene expression linked to tissue remodeling. When all three are present in a system fibroblasts have enhanced capacity for both directed migration toward injury sites and robust matrix synthesis at those sites. GLOW Blend models track fibroblast density migration speed collagen production and organisation of deposited matrix. The data typically show that multi pathway stimulation of fibroblast biology produces more rapid wound closure and more organised granulation tissue compared with control or single peptide groups.
BPC 157 and GHK Cu are both active in promoting synthesis of collagen and other structural proteins. GHK Cu specifically upregulates genes controlling collagen cross linking and interacts with TGF beta signaling which is central to fibrotic tissue organisation. TB 500 supports this process by improving the cellular machinery for synthesis and by promoting angiogenesis which brings blood supply needed to sustain matrix producing cells. In GLOW Blend experiments investigators often measure not only the speed of matrix deposition but also its architecture quality and mechanical properties. Assays include hydroxyproline content collagen type ratios fibre alignment under polarised microscopy tensile strength testing and scar versus normal tissue comparison. Results generally indicate that the combined peptide environment shifts healing toward more organised physiologic matrix rather than disorganised scar tissue.
Each constituent peptide in GLOW Blend has been shown to influence oxidative stress and inflammatory mediator production. BPC 157 modulates reactive oxygen species and supports barrier integrity which limits inflammatory cell infiltration. TB 500 reduces inflammatory cytokine production and supports resolution of early inflammatory phases.
GHK Cu exerts direct antioxidant activity and regulates gene expression linked to oxidative stress response. These three act on overlapping but distinct mechanisms which means GLOW Blend creates a more comprehensive anti inflammatory environment than single agents. Research models track pro and anti inflammatory cytokine profiles tissue macrophage phenotypes neutrophil infiltration and oxidative stress markers such as lipid peroxidation products. In these assays GLOW Blend typically produces faster resolution of the inflammatory phase and earlier transition to the remodeling phase of healing compared with controls.
In tendon and muscle injury models all three peptides in GLOW Blend are relevant. BPC 157 has been studied specifically in tendon healing where it influences collagen deposition and vessel growth. TB 500 acts on muscle regeneration through both direct effects on myogenic cells and support of angiogenesis which sustains muscle recovery.
GHK Cu promotes collagen synthesis and angiogenesis both critical for tendon and muscle healing. Researchers combine these peptides to create a complete pro regenerative stimulus that addresses the multiple biological challenges in musculoskeletal injury namely vessel growth fiber reorganisation and inflammatory containment. Typical endpoints include functional testing of strength and range of motion histologic scoring of tissue architecture immunophenotyping of infiltrating immune cells and transcriptional profiling of repair associated genes.
Skin represents a complex multi layered system where epidermis dermis and microvascular compartments all require coordinated repair. GHK Cu is a particularly strong tool in skin models because it influences hair follicle biology and dermal fibroblast activity. BPC 157 and TB 500 both support angiogenesis and epithelial cell migration which are central to wound closure and skin barrier restoration. GLOW Blend experiments in dermal wounds track re epithelialisation kinetics angiogenesis depth of granulation tissue collagen organisation and long term scar appearance and flexibility. The multi peptide approach allows investigators to test whether coordinated pathway activation produces superior wound closure and better cosmetic outcomes compared with single agent or control groups.
Post surgical wounds present a particular challenge because they involve controlled incisions through multiple tissue planes that must all heal coordinately.
GLOW Blend is well suited to these models because it addresses vascular needs matrix remodeling and inflammation across the full thickness of surgical wounds.
Researchers design protocols that mimic clinical recovery timelines and track functional outcomes alongside histologic and molecular endpoints.
Comparisons often reveal that GLOW Blend accelerates early phase healing improves matrix organisation and produces better long term mechanical properties than standard care or single peptide controls.
Beyond empirical outcome measures some research with GLOW Blend focuses on pathway interaction itself. Do BPC 157 and TB 500 enhance each others signaling at the level of growth factor receptors and downstream cascades. Does GHK Cu copper availability limit or enhance the activity of the other two peptides. Which pathways dominate at different timepoints during healing. These questions use GLOW Blend as a tool to reveal whether the three peptides show additive effects independent activation or true synergy where the combination is greater than the sum of parts. Answering these questions advances understanding of tissue repair biology and helps design future multi component therapeutics.
Across laboratories GLOW Blend is commonly used in acute wound models in skin and other tissues tendon and muscle injury repair paradigms surgical incision and recovery models dermal fibroblast and angiogenesis co culture systems chronically inflamed or slowly healing tissue models comparative studies of mono peptide versus multi peptide exposure. In every case GLOW Blend is a research tool for studying tissue regeneration not a finished therapeutic or cosmetic product.
All findings summarised here arise from controlled in vitro systems ex vivo preparations and animal models under defined protocols. They are provided only to inform qualified researchers about how BPC 157 TB 500 and GHK Cu are used in combination within experimental frameworks. These observations do not demonstrate or imply that GLOW Blend is safe or effective for any human or veterinary indication. They are not dosing instructions medical advice or guidance for wound care hair growth cosmetic enhancement surgical recovery or any other clinical use. GLOW Blend supplied is intended strictly for laboratory research applications.
It is not for human or veterinary use and must not be used for diagnosis treatment cure prevention or mitigation of any disease cosmetic condition or physical concern.
Rango de precios: desde $50.00 hasta $95.00
BPC 157: Un pentadecapéptido sintético utilizado en modelos de laboratorio para investigar la angiogénesis, la migración de fibroblastos y la integridad de la barrera mucosa.
Rango de precios: desde $150.00 hasta $350.00
Retatrutida: Un agonista de triple receptor (GLP-1, GIP y glucagón) destinado a la investigación de la señalización metabólica, la regulación de la glucosa y el balance energético.
$145.00
GROW Blend: Una mezcla de investigación de doble vía que combina CJC 1295 sin DAC (5 mg) e Ipamorelina (5 mg).
Rango de precios: desde $175.00 hasta $275.00
NAD: Una coenzima metabólica central utilizada en ensayos de laboratorio para estudiar la bioenergética mitocondrial, la actividad de las sirtuinas y las vías de señalización dependientes de NAD.
